Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection

Acta Biomedica

Volumn 83, Issue SUPPL.1, 2012, Pages 36-39

  Vento, Giovanni ^a   Tana, M ^a   Tirone, C ^a   Aurilia, C ^a   Lio, A ^a   Perelli, S ^a   Ricci, C ^a   Romagnoli, C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Pneumonia; Premature nonates; Surfactant

Indexed keywords

PORACTANT;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

EID: 84874088889     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Soll RF. Current Trials in the Treatment of Respiratory Failure in Preterm Infants. Neonatology 2009; 95 (4): 368-72.
2. Khammash H, Perlman M, Wojtulewicz J, et al. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92: 135-39.
3. Dragaville PA, South M, Mc Dougall PN. Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001; 138 (1): 113-5.
4. Wiswell TE, Knight GR, Finer NN, et al. A multicenter, randomized, controlled trial comparing surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109(6): 1081-7.
5. Kennedy M, Phelps D, Ingenito E. Mechanisms of surfactant dysfunction in early acute lung injury. Exp Lung Res 1997; 23 (3): 171-89.
6. Herting E, Sun B, Jarstrand C, et al. Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia. Arch Dis Childhood 1997: 76 (1): F3-F8. Special issue.
7. Song GW, Robertson B, Curstedt T, et al. Surfactant treatment in experimental Escherichia Coli pneumonia. Acta Anaesthesiol Scand 1996; 40 (9): 1154-60.
8. Tana M, Zecca E, Tirone C, et al. Target fraction of inspired oxygen during open lung strategy in neonatal high frequency oscillatory ventilation: a retrospective study. Minerva Anestesiol 2012; 78 (2): 151-9.
9. Lotze A, Mitchell BR, Bulas DJ, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 1998; 132: 40-7.
10. Herting E, Gefeller O, Land M, et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000; 106: 957-64.